SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-005618
Filing Date
2019-06-11
Accepted
2019-06-11 16:21:50
Documents
58
Period of Report
2019-04-30

Document Format Files

Seq Description Document Type Size
1 bpmx-20190430x10q.htm 10-Q 1517888
2 bpmx-20190430ex311739b2d.htm EX-31.1 19562
3 bpmx-20190430ex312a089c0.htm EX-31.2 19661
4 bpmx-20190430ex3218c8aae.htm EX-32.1 10139
5 bpmx-20190430ex322ec878b.htm EX-32.2 9979
  Complete submission text file 0001558370-19-005618.txt   5185858

Data Files

Seq Description Document Type Size
6 bpmx-20190430.xml EX-101.INS 1018648
7 bpmx-20190430.xsd EX-101.SCH 35836
8 bpmx-20190430_cal.xml EX-101.CAL 36483
9 bpmx-20190430_def.xml EX-101.DEF 130961
10 bpmx-20190430_lab.xml EX-101.LAB 309030
11 bpmx-20190430_pre.xml EX-101.PRE 258768
Mailing Address 115 NICHOLSON LANE SAN JOSE CA 95134
Business Address 115 NICHOLSON LANE SAN JOSE CA 95134 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 19891234
SIC: 2834 Pharmaceutical Preparations